After opening the day on a positive note, Indian equity markets have continued to witness buying interest during the previous two hours of trade. Realty and FMCG stocks are the leading gainers. Banking and pharma stocks are the leading losers.
The BSE-Sensex is up by 70 points and NSE-Nifty is up by 17 points. BSE Mid Cap index and BSE Small Cap index are trading up by 0.1%. The rupee is trading at 62.18 to the US dollar.
Majority of the Indian pharmaceutical stocks are trading in the green. Wockhardt Ltd and Ipca labs are the leading gainers while Ranbaxy and Sun Pharma are trading the weakest. According to a leading financial daily, Cipla has been awarded a tender worth Rs 11.7 bn for antiretroviral drugs by The Global Fund to Fight AIDS, Tuberculosis and Malaria. Cipla has been selected as a 'panel supplier' under a supplier partnership agreement. The contract is effective from January 1 and will run for three years. The supplies will begin from the fourth quarter of FY15. The antiretroviral drugs will be manufactured in Cipla's facilities in India.
Mining stocks are trading on a positive note. Sesa Sterlite and Hindustan Zinc are the leading gainers. According to a leading financial daily, Hindalco Industries has bagged the Kathautia coal block in Jharkhand for Rs 28.6 bn a tonne on the second day of coal auction. This would imply that the company would pay Rs 2.2 bn a year and Rs 68 bn for a period of 30 years. The block is for end-use in the unregulated sector - iron, steel, cement and captive power generation. GMR and Reliance Cement bagged one mine each yesterday for an estimated Rs 13.7 bn and Rs 7.9 bn respectively. Hindalco is trading up by 0.6% on the BSE.
For information on how to pick stocks that have the potential to deliver big returns, download our special report now!
Read the latest Market Commentary
Equitymaster requests your view! Post a comment on "Indian Indices trade positively". Click here!
Comments are moderated by Equitymaster, in accordance with the Terms of Use, and may not appear
on this article until they have been reviewed and deemed appropriate for posting.
In the meantime, you may want to share this article with your friends!